• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波斯尼亚和黑塞哥维那普通人群中罕见 F5 变异体的流行率。

Prevalence of rare F5 variants in general population from Bosnia and Herzegovina.

机构信息

Department of Genetics and Bioengineering, International Burch University, Francuske revolucije bb, 71000, Sarajevo, Bosnia and Herzegovina.

Labor Dr. Heidrich Und Kollegen MVZ GmbH, Stuvkamp 22, 22081, Hamburg, Germany.

出版信息

Mol Biol Rep. 2021 Jun;48(6):5181-5186. doi: 10.1007/s11033-021-06519-2. Epub 2021 Jul 2.

DOI:10.1007/s11033-021-06519-2
PMID:34215992
Abstract

Human gene F5, encoding coagulation factor V, was previously reported to be highly polymorphic. Apart from FV Leiden, several other rare variants have been detected in clinical practice and associated with thrombotic events, especially in cases when patient's phenotype and FV Leiden genotype were not in agreement. In this study, the prevalence of 17 rare F5 variants has been studied on a sample of 130 healthy adult individuals from the general Bosnian-Herzegovinian population. DNA was isolated from buccal swab samples, while genotyping was performed using MALDI-TOF MS method. The results have shown that Asp2194Gly and Met2120Thr are polymorphic in the study population with minor allele frequencies of 0.077 and 0.073, respectively. Additionally, these two variants were mutually exclusive with FV Leiden and none of them was positively associated with participants' family history of cardiovascular or cerebrovascular diseases. While the obtained results are in agreement with previously reported data for the general Caucasian populations, it is worth noting that only two rare F5 variants were detected in the study population, albeit at considerable frequencies. Still, scientific information on rare F5 variants is rather scarce and further studies aiming to assess functional importance of these variants, as well as their role as prothrombotic factors are necessary.

摘要

人类基因 F5 编码凝血因子 V,先前被报道高度多态性。除了 FV Leiden 之外,在临床实践中还检测到了几种其他罕见的变体,与血栓事件相关,尤其是在患者表型和 FV Leiden 基因型不一致的情况下。在这项研究中,在来自普通波斯尼亚和黑塞哥维那人群的 130 名健康成年个体的样本中研究了 17 种罕见的 F5 变体的流行率。从口腔拭子样本中分离 DNA,而使用 MALDI-TOF MS 方法进行基因分型。结果表明,Asp2194Gly 和 Met2120Thr 在研究人群中是多态性的,其次要等位基因频率分别为 0.077 和 0.073。此外,这两个变体与 FV Leiden 相互排斥,并且它们都与参与者的心血管或脑血管疾病家族史无关。虽然获得的结果与先前报告的一般白种人群的数据一致,但值得注意的是,尽管频率相当高,但在研究人群中仅检测到两种罕见的 F5 变体。尽管如此,关于罕见 F5 变体的科学信息相当匮乏,有必要进一步研究这些变体的功能重要性及其作为促血栓形成因子的作用。

相似文献

1
Prevalence of rare F5 variants in general population from Bosnia and Herzegovina.波斯尼亚和黑塞哥维那普通人群中罕见 F5 变异体的流行率。
Mol Biol Rep. 2021 Jun;48(6):5181-5186. doi: 10.1007/s11033-021-06519-2. Epub 2021 Jul 2.
2
Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina.波斯尼亚和黑塞哥维那华法林患病率的血栓形成倾向标志物和药物遗传学标志物的人群研究。
Croat Med J. 2019 Jun 13;60(3):212-220. doi: 10.3325/cmj.2019.60.212.
3
Modulation of factor V levels in plasma by polymorphisms in the C2 domain.C2结构域多态性对血浆中凝血因子V水平的调节作用。
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):200-6. doi: 10.1161/01.ATV.0000109750.34073.f6. Epub 2003 Dec 1.
4
Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population.遗传性血栓形成风险因素的患病率:波斯尼亚人群中的FV基因1691G>A突变、PT基因20210G>A突变和MTHFR基因677C>T突变
Ann Hum Biol. 2015;42(6):576-80. doi: 10.3109/03014460.2014.968618. Epub 2014 Oct 30.
5
Prevalence of F5 1691G>A, F2 20210G>A, and MTHFR 677C>T polymorphisms in Bosnian women with pregnancy loss.波斯尼亚女性妊娠丢失与 F5 1691G>A、F2 20210G>A 和 MTHFR 677C>T 多态性的相关性研究。
Bosn J Basic Med Sci. 2017 Nov 20;17(4):309-314. doi: 10.17305/bjbms.2017.1954.
6
Prevalence of 1691G>A FV mutation in females from Bosnia and Herzegovina--a preliminary report.1691G>A FV 突变在波斯尼亚和黑塞哥维那女性中的流行情况——初步报告。
Bosn J Basic Med Sci. 2013 Feb;13(1):31-3. doi: 10.17305/bjbms.2013.2410.
7
Allele frequencies of 15 STR loci in Bosnian and Herzegovinian population.波斯尼亚和黑塞哥维那人群中15个STR基因座的等位基因频率。
Croat Med J. 2017 Jun 14;58(3):250-256. doi: 10.3325/cmj.2017.58.250.
8
Molecular diversity of 23 Y-chromosome short tandem repeat loci in the population of Tuzla Canton, Bosnia and Herzegovina.波斯尼亚和黑塞哥维那图兹拉州人群中23个Y染色体短串联重复序列位点的分子多样性
Ann Hum Biol. 2017 Aug;44(5):419-426. doi: 10.1080/03014460.2016.1259430. Epub 2016 Nov 30.
9
Haplotype data for 23 Y-chromosome markers in a reference sample from Bosnia and Herzegovina.波斯尼亚和黑塞哥维那参考样本中23个Y染色体标记的单倍型数据。
Croat Med J. 2013 Jun;54(3):286-90. doi: 10.3325/cmj.2013.54.286.
10
Analysis of forensic genetic parameters of 22 autosomal STR markers (PowerPlex® Fusion System) in a population sample from Bosnia and Herzegovina.波斯尼亚和黑塞哥维那人群样本中22个常染色体STR标记(PowerPlex® Fusion系统)的法医遗传学参数分析。
Ann Hum Biol. 2020 May;47(3):273-283. doi: 10.1080/03014460.2020.1740319. Epub 2020 Apr 17.

引用本文的文献

1
Population Pharmacogenomics in Croatia: Evaluating the PGx Allele Frequency and the Impact of Treatment Efficiency.克罗地亚的人群药物基因组学:评估 PGx 等位基因频率和治疗效果的影响。
Int J Mol Sci. 2023 Aug 31;24(17):13498. doi: 10.3390/ijms241713498.

本文引用的文献

1
Population study of thrombophilic markers and pharmacogenetic markers of warfarin prevalence in Bosnia and Herzegovina.波斯尼亚和黑塞哥维那华法林患病率的血栓形成倾向标志物和药物遗传学标志物的人群研究。
Croat Med J. 2019 Jun 13;60(3):212-220. doi: 10.3325/cmj.2019.60.212.
2
ClinVar: improving access to variant interpretations and supporting evidence.ClinVar:改善变异解读和支持证据的获取。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067. doi: 10.1093/nar/gkx1153.
3
Thrombophilic Gene Mutations in Relation to Different Manifestations of Venous Thromboembolism: A Single Tertiary Center Study.
与静脉血栓栓塞不同表现相关的血栓形成倾向基因突变:一项单中心三级研究
Clin Appl Thromb Hemost. 2018 Jan;24(1):100-106. doi: 10.1177/1076029616672585. Epub 2016 Oct 11.
4
The utility of thrombophilia testing.血栓形成倾向检测的效用。
Clin Chem Lab Med. 2014 Apr;52(4):495-7. doi: 10.1515/cclm-2013-0559.
5
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.静脉血栓栓塞风险与因子 V 莱顿、凝血酶原 20210A 和亚甲基四氢叶酸还原酶 C677T 的单一和联合作用相关:一项涉及超过 11000 例病例和 21000 例对照的荟萃分析。
Eur J Epidemiol. 2013 Aug;28(8):621-47. doi: 10.1007/s10654-013-9825-8. Epub 2013 Jul 31.
6
Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.凝血因子V HR2单倍型:无凝血因子V莱顿突变个体发生静脉血栓栓塞的危险因素。
Ann Hematol. 2008 Dec;87(12):1013-6. doi: 10.1007/s00277-008-0543-3. Epub 2008 Jul 25.
7
Inherited defects of coagulation Factor V: the thrombotic side.凝血因子V的遗传性缺陷:血栓形成方面
J Thromb Haemost. 2006 Jan;4(1):35-40. doi: 10.1111/j.1538-7836.2005.01572.x. Epub 2005 Oct 25.
8
Modulation of factor V levels in plasma by polymorphisms in the C2 domain.C2结构域多态性对血浆中凝血因子V水平的调节作用。
Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):200-6. doi: 10.1161/01.ATV.0000109750.34073.f6. Epub 2003 Dec 1.
9
Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C.凝血因子V I359T:一种与血栓形成及对活化蛋白C抵抗相关的新突变。
Br J Haematol. 2003 Nov;123(3):496-501. doi: 10.1046/j.1365-2141.2003.04624.x.
10
The factor V HR2 haplotype and the risk of venous thrombosis: a meta-analysis.因子V HR2单倍型与静脉血栓形成风险:一项荟萃分析。
Haematologica. 2003 Oct;88(10):1182-9.